Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis

Pulmonary Pharmacology and Therapeutics · Published 2026-07-17 · DOI 10.1016/j.pupt.2026.102437

Authors (9)

Karina Kleinfelder, Anca Manuela Hristodor, Giorgio Centin, Antonella Casiraghi, Paola Minghetti, Emily Pintani, Marina Bertini, Claudio Sorio, Paola Melotti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kleinfelder, K., Hristodor, A., Centin, G., et al. (2026). Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis. Pulmonary Pharmacology and Therapeutics. https://doi.org/10.1016/j.pupt.2026.102437

Related articles

• Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients · Pulmonary Pharmacology and Therapeutics · 2026 · Same journal
• Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia · Pulmonary Pharmacology and Therapeutics · 2024 · Same journal
• Prevalence and clinical significance of pre- and post-bronchodilator airflow obstruction in COPD patients · Pulmonary Pharmacology and Therapeutics · 2024 · Same journal
• Drug-drug interactions in vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor-ivacaftor · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal
• Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal
• Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal
• Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment · Pulmonary Pharmacology and Therapeutics · 2026 · Same journal
• Clinical remission at two years post-diagnosis of asthma and its association with clinical outcomes: A retrospective cohort study in asthma patients with maintenance inhaler therapy · Pulmonary Pharmacology and Therapeutics · 2025 · Same journal
• m6A reader IGF2BP2 Mediates Airway Remodeling by Stabilizing Dixdc1 in Asthma Pathogenesis · Pulmonary Pharmacology and Therapeutics · 2026 · Same journal
• Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers · Pulmonary Pharmacology and Therapeutics · 2026 · Same journal